These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
9. A case of an infant with compound heterozygous mutations for hypertrophic cardiomyopathy producing a phenotype of left ventricular noncompaction. Haberer K; Buffo-Sequeira I; Chudley AE; Spriggs E; Sergi C Can J Cardiol; 2014 Oct; 30(10):1249.e1-3. PubMed ID: 25262865 [TBL] [Abstract][Full Text] [Related]
10. Hypertrophic cardiomyopathy in Noonan Syndrome closely mimics familial hypertrophic cardiomyopathy due to sarcomeric mutations. Hudsmith LE; Petersen SE; Francis JM; Robson MD; Watkins H; Neubauer S Int J Cardiovasc Imaging; 2006; 22(3-4):493-5. PubMed ID: 16267621 [TBL] [Abstract][Full Text] [Related]
11. Familial conduction system disease associated with hypertrophic cardiomyopathy. Bahl A; Saikia UN; Talwar KK Int J Cardiol; 2008 Apr; 125(3):e44-7. PubMed ID: 17445920 [TBL] [Abstract][Full Text] [Related]
12. Abnormal Lymphatic Channels Detected by T2-Weighted MR Imaging as a Substrate for Ventricular Arrhythmia in HCM. Kolman L; Welsh DG; Vigmond E; Joncas SX; Stirrat J; Scholl D; Rajchl M; Tweedie E; Mikami Y; Lydell C; Howarth A; Yee R; White JA JACC Cardiovasc Imaging; 2016 Nov; 9(11):1354-1356. PubMed ID: 26777221 [No Abstract] [Full Text] [Related]
13. [Malignant form of familial hypertrophic cardiomyopathy complicated with ventricular fibrillation in siblings. Electrocardiogram in hypertrophic cardiomyopathy - a review]. Kukla P; Petkow-Dimitrow P; Jastrzebski M; Bednarek J; Lelakowski J; Bryniarski L Kardiol Pol; 2009 Jul; 67(7):774-80; discussion 781. PubMed ID: 19650001 [TBL] [Abstract][Full Text] [Related]
14. Age-dependent heterogeneity of familiar hypertrophic cardiomyopathy phenotype: a role of cardiovascular magnetic resonance. Glaveckaitė S; Rudys A; Mikštienė V; Valevičienė N; Palionis D; Laucevičius A Medicina (Kaunas); 2013; 49(9):422-5. PubMed ID: 24589579 [TBL] [Abstract][Full Text] [Related]
15. Lack of Phenotypic Differences by Cardiovascular Magnetic Resonance Imaging in MYH7 (β-Myosin Heavy Chain)- Versus MYBPC3 (Myosin-Binding Protein C)-Related Hypertrophic Cardiomyopathy. Weissler-Snir A; Hindieh W; Gruner C; Fourey D; Appelbaum E; Rowin E; Care M; Lesser JR; Haas TS; Udelson JE; Manning WJ; Olivotto I; Tomberli B; Maron BJ; Maron MS; Crean AM; Rakowski H; Chan RH Circ Cardiovasc Imaging; 2017 Feb; 10(2):. PubMed ID: 28193612 [TBL] [Abstract][Full Text] [Related]
16. The development of familial hypertrophic cardiomyopathy: from mutation to bedside. Brouwer WP; van Dijk SJ; Stienen GJ; van Rossum AC; van der Velden J; Germans T Eur J Clin Invest; 2011 May; 41(5):568-78. PubMed ID: 21158848 [TBL] [Abstract][Full Text] [Related]
17. Magnetic resonance imaging in familial hypertrophic cardiomyopathy associated with abnormal thallium perfusion and cardiac enzymes. Nishimura T; Nagata S; Sakakibara H Jpn Circ J; 1988 May; 52(5):395-400. PubMed ID: 3411762 [TBL] [Abstract][Full Text] [Related]